Get the Stockscreener App
8.44
1.52%
-0.13
After Hours:
8.44
Fennec Pharmaceuticals Inc stock is traded at $8.44, with a volume of 67,283.
It is down -1.52% in the last 24 hours and down -3.65% over the past month.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
See More
Previous Close:
$8.57
Open:
$8.69
24h Volume:
67,283
Relative Volume:
0.96
Market Cap:
$235.57M
Revenue:
$21.25M
Net Income/Loss:
$-16.05M
P/E Ratio:
-13.84
EPS:
-0.61
Net Cash Flow:
$-17.14M
1W Performance:
-13.35%
1M Performance:
-3.65%
6M Performance:
+68.46%
1Y Performance:
+90.95%
1-Day Range:
$8.357
$8.79
1-Week Range:
$8.357
$9.81
52-Week Range:
$3.96
$9.92
Fennec Pharmaceuticals Inc Stock (FENC) Company Profile
Name
Fennec Pharmaceuticals Inc
Sector
Industry
Phone
(919) 636-4530
Address
PO BOX 13628, RESEARCH TRIANGLE PARK, NC
Compare FENC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FENC
Fennec Pharmaceuticals Inc
|
8.44 | 238.52M | 21.25M | -16.05M | -17.14M | -0.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Fennec Pharmaceuticals Inc Stock (FENC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-22-22 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Sep-07-22 | Initiated | CapitalOne | Overweight |
| Aug-08-22 | Resumed | Craig Hallum | Buy |
| Jun-05-20 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-11-18 | Initiated | Goldman | Buy |
Fennec Pharmaceuticals Inc Stock (FENC) Latest News
Is Fennec Pharmaceuticals Inc. stock ready for breakoutWeekly Trade Analysis & Risk Controlled Daily Trade Plans - newser.com
Reversal indicators forming on Fennec Pharmaceuticals Inc. stockJuly 2025 Patterns & Fast Gain Stock Trading Tips - newser.com
Can Fennec Pharmaceuticals Inc. stock deliver consistent earnings growthJuly 2025 Price Swings & Advanced Technical Analysis Signals - newser.com
Identifying reversal signals in Fennec Pharmaceuticals Inc.Take Profit & Capital Efficiency Focused Ideas - newser.com
Why analysts raise outlook for Fennec Pharmaceuticals Inc. (RV41) stock2025 Biggest Moves & Free Reliable Trade Execution Plans - newser.com
Can Fennec Pharmaceuticals Inc. stock withstand economic slowdown2025 Technical Overview & Expert Verified Stock Movement Alerts - newser.com
(FRX) Equity Market Report (FRX:CA) - news.stocktradersdaily.com
Rostislav Christov Raykov Buys 4,609 Shares of Fennec Pharmaceuticals (TSE:FRX) Stock - MarketBeat
Fennec Pharmaceuticals (TSE:FRX) Director Chris Anigeron Rallis Sells 1,775 Shares - MarketBeat
Fennec Pharmaceuticals (TSE:FRX) Insider Sells C$256,237.35 in Stock - MarketBeat
Fennec Pharmaceuticals (TSE:FRX) Insider Southpoint Capital Advisors Lp Sells 26,900 Shares - MarketBeat
Fennec Pharmaceuticals (TSE:FRX) Insider Sells C$265,650.01 in Stock - MarketBeat
Analysts Set Adherex Technologies Inc. (NASDAQ:FENC) Price Target at $13.33 - Defense World
Long term hold vs stop loss in Fennec Pharmaceuticals Inc.Weekly Earnings Recap & Low Risk High Reward Ideas - newser.com
Fennec Pharmaceuticals (TSE:FRX) Shares Pass Above 50 Day Moving AverageHere's What Happened - MarketBeat
Southpoint sells Fennec Pharmaceuticals (FENC) shares worth $636k By Investing.com - Investing.com Canada
(FRX) Trading Report (FRX:CA) - news.stocktradersdaily.com
Is now a turning point for Fennec Pharmaceuticals Inc.July 2025 Update & Real-Time Chart Pattern Alerts - newser.com
Southpoint sells Fennec Pharmaceuticals (FENC) shares worth $636k - Investing.com
Fennec Pharmaceuticals Inc. stock trend forecast2025 Market Outlook & Stepwise Entry and Exit Trade Signals - newser.com
How Fennec Pharmaceuticals Inc. (RV41) stock benefits from digital adoptionJuly 2025 Opening Moves & Fast Gaining Stock Reports - newser.com
Will Fennec Pharmaceuticals Inc. stock recover after recent dropJuly 2025 Fed Impact & Smart Investment Allocation Tips - newser.com
Will Fennec Pharmaceuticals Inc. stock benefit from AI adoptionPortfolio Performance Summary & Smart Money Movement Tracker - newser.com
Can Fennec Pharmaceuticals Inc. stock hit analyst price targetsRate Cut & High Conviction Buy Zone Alerts - newser.com
Can Fennec Pharmaceuticals Inc. rally from current levelsJuly 2025 Movers & High Yield Equity Trading Tips - newser.com
Adherex Technologies (NASDAQ:FENC) Trading Down 1.4% After Insider Selling - Defense World
Learn to Evaluate (FRX) using the Charts (FRX:CA) - news.stocktradersdaily.com
What drives Fennec Pharmaceuticals Inc stock priceDividend Stability Analysis & Free Take Advantage Of Momentum - earlytimes.in
Fennec Pharmaceuticals (TSE:FRX) Reaches New 1-Year HighStill a Buy? - MarketBeat
Raykov Rosty sells Fennec Pharmaceuticals (FENC) shares for $97,800 - Investing.com
What downside risks could hit Fennec Pharmaceuticals Inc. (RV41) stockPortfolio Performance Summary & Real-Time Sentiment Analysis - newser.com
Using AI based signals to follow Fennec Pharmaceuticals Inc.July 2025 Summary & Safe Capital Preservation Plans - newser.com
Is Fennec Pharmaceuticals Inc. stock positioned well for digital economy2025 Historical Comparison & Real-Time Stock Entry Alerts - newser.com
How buyback programs support Fennec Pharmaceuticals Inc. (RV41) stockWall Street Watch & Technical Entry and Exit Alerts - newser.com
(FRX) Equity Trading Insights (FRX:CA) - news.stocktradersdaily.com
Using Ichimoku Cloud for Fennec Pharmaceuticals Inc. technicalsOptions Play & High Accuracy Trade Signal Alerts - newser.com
Chart based analysis of Fennec Pharmaceuticals Inc. trendsQuarterly Portfolio Review & Risk Managed Investment Strategies - newser.com
Can Fennec Pharmaceuticals Inc. (RV41) stock sustain double digit ROEJuly 2025 Opening Moves & Low Risk Investment Opportunities - newser.com
Fennec Pharmaceuticals Hits Day High with Strong 7.98% Intraday Surge - Markets Mojo
Fennec Pharmaceuticals Inc Stock (FENC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Fennec Pharmaceuticals Inc Stock (FENC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Southpoint Capital Advisors LP | 10% Owner |
Oct 07 '25 |
Sale |
9.59 |
26,900 |
257,893 |
4,050,314 |
| Southpoint Capital Advisors LP | 10% Owner |
Oct 09 '25 |
Sale |
9.35 |
20,609 |
192,614 |
4,010,100 |
| Southpoint Capital Advisors LP | 10% Owner |
Oct 08 '25 |
Sale |
9.47 |
19,605 |
185,722 |
4,030,709 |
| Raykov Rosty | Director |
Oct 08 '25 |
Option Exercise |
2.45 |
4,609 |
11,292 |
87,110 |
| Raykov Rosty | Director |
Oct 06 '25 |
Sale |
9.78 |
10,000 |
97,800 |
82,501 |
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):